Prosecution Insights
Last updated: April 19, 2026

VANDERBILT UNIVERSITY

46 pending office actions

Portfolio Summary

46
Total Pending OAs
13
Final Rejections
33
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19246456 SYSTEM AND METHOD FOR PROVIDING THERMAL HAPTIC FEEDBACK IN A VIRTUAL OR AUGMENTED REALITY MA, CALVIN 2629 Non-Final OA Jun 23, 2025
18893214 MOMENT ARM EXTENSION SYSTEM FOR EXOSUIT MILO, MICHAEL 3786 Non-Final OA Sep 23, 2024
18743323 SYSTEMS FOR IN-CAGE ANIMAL BEHAVIOR SENSING MONSUR, NASIMA 2858 Non-Final OA Jun 14, 2024
18710849 NASAL TRANS-ESOPHAGEAL ECHOCARDIOGRAPHY SYSTEM AND DEVICE FARAG, AMAL ALY 3798 Non-Final OA May 16, 2024
18693572 METHOD AND SYSTEM FOR AUTOMATIC SEGMENTATION OF STRUCTURES OF INTEREST IN MR IMAGES USING A WEIGHTED ACTIVE SHAPE MODEL SCHWARTZ, RAPHAEL M 2671 Non-Final OA Mar 20, 2024
18686663 ENDOSCOPIC RETINACULATOME NEAL, TIMOTHY JAY 3795 Non-Final OA Feb 26, 2024
18684796 SYSTEMS AND METHODS OF IMPROVING SLEEP DISORDERED BREATHING STICE, PAULA J 3796 Non-Final OA Feb 19, 2024
18575437 FLUID SHEAR STRESS FOR EX VIVO ACTIVATION OF IMMUNE EFFECTOR CELLS BARRON, SEAN C 1653 Non-Final OA Dec 29, 2023
18567888 COMPOSITE FIBER INKS AND ELECTRODES AND APPLICATIONS OF SAME ALEJANDRO, RAYMOND 1752 Non-Final OA Dec 07, 2023
18531168 TARGETING ANTI-HUMAN PD 1H/VISTA TO TREAT HEMATOLOGIC DISORDERS NICKOL, GARY B 1643 Non-Final OA Dec 06, 2023
18563804 MACROLIDE COMPOUNDS KRISHNAN, GANAPATHY 1693 Non-Final OA Nov 22, 2023
18559184 WDR5 INHIBITORS AND MODULATORS TRAN, ERIC 1629 Non-Final OA Nov 06, 2023
18381126 Markers of Triple-Negative Breast Cancer and Uses Thereof SALMON, KATHERINE D 1682 Final Rejection Oct 17, 2023
18379251 SYSTEM FOR FACILITATING DIFFERENTIATION BETWEEN PARATHYROID TISSUE AND THYROID TISSUE AND APPLICATIONS OF SAME MUSTANSIR, ABID A 3791 Final Rejection Oct 12, 2023
18550996 NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 COPPINS, JANET L 1628 Non-Final OA Sep 18, 2023
18454285 OPTOELECTROFLUIDIC DEVICE FOR MASSIVE PARALLEL TRAPPING AND ENHANCED SPECTROSCOPY OF SINGLE NANOSCALE OBJECTS CHOI, JAMES J 2878 Non-Final OA Aug 23, 2023
18264741 A CONTINUOUS METRIC TO MEASURE ENDOTYPE AND CORTICOSTEROID INTERACTION IN SEPTIC SHOCK CASH, KAILEY ELIZABETH 1683 Non-Final OA Aug 08, 2023
18364809 PCR DETECTION OF SMALL FRAGMENTS OF A KNOWN NUCLEIC ACID TARGET HORLICK, KENNETH R 1681 Non-Final OA Aug 03, 2023
18226204 HUMAN ADAPTABLE VARIABLE STIFFNESS SPRINGS DVORAK, LINDA C 3794 Non-Final OA Jul 25, 2023
18223785 SYSTEMS AND METHODS OF OPTICAL NEURAL STIMULATION FOR INTRAOPERATIVE NERVE MONITORING TU, AURELIE H 3791 Non-Final OA Jul 19, 2023
18272919 COMBINATION OF INTRACELLULAR AND EXTRACELLULAR PHOTOSENSITIZERS FOR TREATMENT OF BACTERIAL INFECTION BORALSKY, LUKE ALAN 1624 Non-Final OA Jul 18, 2023
18268009 CLASS OF BIOMATERIALS FOR PROMOTING LARGE BLOOD VESSEL GROWTH CESARE, JOSEPH DAVID 1675 Non-Final OA Jun 16, 2023
18324828 L-DNA ENCRYPTED TRACERS CASH, KAILEY ELIZABETH 1683 Non-Final OA May 26, 2023
18253094 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 SOLOLA, TAOFIQ A 1625 Non-Final OA May 16, 2023
18306466 SELF-BALANCING HARNESS FOR WEARABLE ASSISTANCE DEVICES DAHER, KIRA B 3785 Non-Final OA Apr 25, 2023
18134539 METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS CHONG, YONG SOO 1623 Final Rejection Apr 13, 2023
18030434 SIDE VIEWING ENDOSCOPIC ENDCAP SURGAN, ALEXANDRA L 3799 Non-Final OA Apr 05, 2023
18179941 MULTI-ARTICULATED CATHETERS WITH SAFETY METHODS AND SYSTEMS FOR IMAGE-GUIDED COLLABORATIVE INTRAVASCULAR DEPLOYMENT NGO, MEAGAN N 3781 Final Rejection Mar 07, 2023
18177068 LIPOPHILIC SIRNA CONJUGATES FOR THE TREATMENT OF INFLAMMATORY DISEASES SULLIVAN, STEPHANIE LAUREN 1635 Non-Final OA Mar 01, 2023
18173983 POWERED-ON PASSIVE KNEE PROSTHESIS SYSTEM SNOW, BRUCE EDWARD 3774 Non-Final OA Feb 24, 2023
18065360 MINI-PROMOTER NGUYEN, QUANG 1631 Non-Final OA Dec 13, 2022
17928765 USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS BARSKY, JARED 1628 Final Rejection Nov 30, 2022
17993218 SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR ENHANCED LEARNING USING BRAIN-GUIDED NON-INVASIVE BRAIN STIMULATION HUSSAINI, ATTIYA SAYYADA 3792 Final Rejection Nov 23, 2022
17998433 METHODS OF TREATING SJÖGRENS SYNDROME PIHONAK, SARAH 1627 Final Rejection Nov 10, 2022
17920710 HYOLARYNGEAL SUSPENSION FOR TREATING SLEEP DISORDERED BREATHING FISHER, VICTORIA HICKS 3786 Final Rejection Oct 21, 2022
17917651 RECOMBINANT VACCINES AND METHODS OF USE THEREOF BELYAVSKYI, MICHAIL A 1644 Non-Final OA Oct 07, 2022
17820418 CROSS-REACTIVE ANTIBODIES AND USES THEREOF LEE, YIE CHIA 1642 Final Rejection Aug 17, 2022
17780782 PROTON TRANSPORT MEMBRANES AND METHODS OF MAKING AND USE THEREOF BUCHANAN, JACOB 1725 Non-Final OA May 27, 2022
17691567 DUAL WAVELENGTH COMBINED FINGERPRINT AND HIGH WAVENUMBER RAMAN SPECTROSCOPY AND APPLICATIONS OF SAME FERNANDES, PATRICK M 3791 Non-Final OA Mar 10, 2022
17618829 AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF PATEL, SAGAR S 1626 Final Rejection Dec 13, 2021
17618838 DIBENZYLAMINES AS AMINO ACID TRANSPORT INHIBITORS SEITZ, ANTHONY JOSEPH 1629 Final Rejection Dec 13, 2021
17602222 PATENT DUCTUS ARTERIOSUS STENT BLASS, PARIS MARIE 3774 Non-Final OA Oct 07, 2021
17459652 SYSTEMATIC IDENTIFICATION OF CANDIDATES FOR GENETIC TESTING USING CLINICAL DATA AND MACHINE LEARNING AUGER, NOAH ANDREW 1687 Non-Final OA Aug 27, 2021
17429540 BIOFUNCTIONALIZED HYDROGEL FOR CELL CULTURE ZHU, JIANJIAN 1631 Final Rejection Aug 09, 2021
17275764 METHODS AND COMPOSITIONS FOR TREATING SKIN DISEASES DABKOWSKI, ERINNE R 1654 Non-Final OA Mar 12, 2021
17180816 MANIPULATING THE CIRCADIAN CLOCK TO INCREASE GENE EXPRESSION SHARMA, SANTOSH 1663 Final Rejection Feb 21, 2021

Managing VANDERBILT UNIVERSITY's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month